Regulus Therapeutics Inc. — Net Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/9c2306f6-7ea6-4965-843d-6b2133a3a6a6/serie/net-income

Fiscal year	Net Income	Period	Evidence
FY 2024	$-46.4M	2024-01-01 – 2024-12-31	evidence 0001628280-25-012627
FY 2023	$-30.0M	2023-01-01 – 2023-12-31	evidence 0001628280-24-012543
FY 2022	$-28.3M	2022-01-01 – 2022-12-31	evidence 0001628280-23-009061
FY 2021	$-27.8M	2021-01-01 – 2021-12-31	evidence 0001628280-22-005771
FY 2020	$-15.7M	2020-01-01 – 2020-12-31	evidence 0001628280-21-004294
FY 2019	$-18.6M	2019-01-01 – 2019-12-31	evidence 0001628280-20-003483
FY 2018	$-48.7M	2018-01-01 – 2018-12-31	evidence 0001628280-19-003037
FY 2017	$-71.9M	2017-01-01 – 2017-12-31	evidence 0001628280-18-002874
FY 2016	$-81.8M	2016-01-01 – 2016-12-31	evidence 0001628280-17-002123
FY 2015	$-55.7M	2015-01-01 – 2015-12-31	evidence 0001628280-16-011521
FY 2014	$-56.7M	2014-01-01 – 2014-12-31	evidence 0001193125-15-052948
FY 2013	$-18.7M	2013-01-01 – 2013-12-31	evidence 0001193125-14-074001
FY 2012	$-17.4M	2012-01-01 – 2012-12-31	evidence 0001193125-13-065164
FY 2011	$-7.6M	2011-01-01 – 2011-12-31	evidence 0001193125-13-065164
FY 2010	$-15.6M	2010-01-01 – 2010-12-31	evidence 0001193125-13-065164

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Regulus Therapeutics Inc. — all facts · Revenue · Operating Income